ema prac naion semaglutide very rare side effect 2025 considers serious eye condition a 'very rare' of PRAC assesses that NAION could

Sumera Ahmed, MD, of the Metabolic Research Center, College of Osteopathic Medicine at Touro University, CA, not involved in the current study, said that for now: We would still need to await the results of the Having semaglutide available as an oral or injectable allows accommodation for patient preferences, said Vanita R

Ongoing Monitoring: Every 3-6 months, or as advised by your healthcare provider

The company said the pricing would be available to eligible U.S

With over 14 years of clinical trial data and 7 years of real-world use, semaglutide represents one of the more thoroughly studied medications in its class, though it's important to recognize that very long-term data (beyond 57 years of continuous use) remains limited

When the body has a change in sugar level, it can affect the shape of the lens of the eye

Limitations Although this study provides clinically meaningful findings, several limitations should be acknowledged